Economic Burden of Relapsed or Refractory Multiple Myeloma: Results from an International Trial.

CONCLUSIONS: Substantial RRMM indirect, social costs were observed. Better major tumor response may reduce hospitalization visits. This article is protected by copyright. All rights reserved.
PMID: 28306169 [PubMed - as supplied by publisher]

Source: Pain Physician - March 16, 2017 Category: Anesthesiology Authors: Robinson D, Orlowski RZ, Stokes M, He J, Huse S, Chitnis A, Kranenburg B, Lam A Tags: Eur J Haematol Source Type: research